Indoleamine-2,3-dioxygenase 1

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Indoleamine-2,3-dioxygenase 1 or IDO or IDO-1 is more commonly known as IDO1 is an enzyme in the kynurenine pathway involved in the metabolism of the essential amino acid tryptophan to N-formyl kynurenine.[1][2] The gene encoding IDO1 is also sometimes referred to as IDO1.[1]

Function[edit | edit source]

ME/CFS[edit | edit source]

Notable studies and publications[edit | edit source]

  • 2019, The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS[3] (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

  • IDO1 - National Center for Biotechnology Information

References[edit | edit source]

  1. 1.0 1.1 National Center for Biotechnology Information (March 22, 2020). "IDO1 indoleamine 2,3-dioxygenase 1 [Homo sapiens (human)] - Gene - NCBI". ncbi.nlm.nih.gov. Retrieved May 1, 2020.
  2. Ball, Helen J.; Yuasa, Hajime J.; Austin, Christopher J.D.; Weiser, Silvia; Hunt, Nicholas H. (March 1, 2009). "Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway". The International Journal of Biochemistry & Cell Biology. 41 (3): 467–471. doi:10.1016/j.biocel.2008.01.005. ISSN 1357-2725.
  3. Phair, RobertD.; Davis, Ronald W.; Kashi, Alex A. (2019). "The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS". Diagnostics. 9 (3): 82. doi:10.3390/diagnostics9030082.